TY  - JOUR 
T1  - All about blinatumomab: the bispecific T cell engager immunotherapy for B cell acute lymphoblastic leukemia
JO  - Hematology, Transfusion and Cell Therapy
A1  - Mirfakhraie, Reza
A1  - Dehaghi, Bentolhoda Kuhestani
A1  - Ghorbi, Mahmoud Dehghani
A1  - Ghaffari-Nazari, Haniyeh
A1  - Mohammadian, Mozhdeh
A1  - Salimi, Maryam
A1  - Ardakani, Maria Tavakoli
A1  - Parkhideh, Sayeh
SN  - 2531-1379
UL  - 10.1016/j.htct.2023.06.006
VL  - 46 
Y1  - 2024
PB  - Brasil 
ER  -